CD8A and melanoma: Tumor-infiltrating CD8+ T cells expressing TRM markers found in biopsies are associated with a favorable prognosis for numerous solid tumors, including melanoma (15), breast cancer (16), ovarian cancer (17), cervical cancer (18), and lung cancer (19).